Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 1.12.2022Zentiva, k.s. (ZNT-1)5023DPenlac 500 mg/125 mg (tbl flm 21x500 mg/125 mg (blis.OPA/Al/PVC/Al))1.12.2022R
 1.12.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)20884Tulip 10 mg filmom obalené tablety (tbl flm 30x10 mg (blis.Al/Al))1.12.2022R
 1.12.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)20895Tulip 10 mg filmom obalené tablety (tbl flm 90x10 mg (blis.Al/Al))1.12.2022R
 1.12.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)20905Tulip 20 mg filmom obalené tablety (tbl flm 30x20 mg (blis.Al/Al))1.12.2022R
 1.12.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)20916Tulip 20 mg filmom obalené tablety (tbl flm 90x20 mg (blis.Al/Al))1.12.2022R
 1.12.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)28912Ospamox 750 mg filmom obalené tablety (tbl flm 14x750 mg (blis.PVC/PVDC/Al))1.12.2022R
 1.12.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)28913Ospamox 1000 mg filmom obalené tablety (tbl flm 14x1000 mg (blis.PVC/PVDC/Al))1.12.2022R
 1.12.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)66366Ospamox 250 mg/5 ml prášok na perorálnu suspenziu (plu por 1x60 ml (fľ.skl.žltohnedá+PP odmer.lyžička))1.12.2022R
 1.12.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)89109PERINDASAN 2 mg/0,625 mg tablety (tbl 30x2 mg/0,625 mg (blis.Al/Al))1.12.2022R
 1.12.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)89129PERINDASAN 4 mg/1,25 mg tablety (tbl 30x4 mg/1,25 mg (blis.Al/Al))1.12.2022R
 1.12.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)89132PERINDASAN 4 mg/1,25 mg tablety (tbl 90x4 mg/1,25 mg (blis.Al/Al))1.12.2022R
 1.12.2022Sandoz GmbH (SAN-A)45996Ospen 500 (tbl flm 30x500 KU (blis.Al/PVC/PVDC))1.12.2022R
 1.12.2022Sandoz GmbH (SAN-A)45998Ospen 1500 (tbl flm 30x1500 KU (blis.Al/PVC/PVDC))1.12.2022R
 1.12.2022Mylan IRE Healthcare Limited (MYR)96970Fraxiparine 2 850 IU (anti Xa)/0,3 ml (sol inj 10x0,3 ml/2,85 KU (striek.inj.skl.napl.))2.12.2022R
 1.12.2022Mylan IRE Healthcare Limited (MYR)96988Fraxiparine 9 500 IU (anti-Xa)/1 ml (sol inj 10x1 ml/9,5 KU (striek.inj.skl.napl.))2.12.2022R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)